{
  "symbol": "bgmd",
  "name": "BG Medicine, Inc.",
  "ipoYear": 2011,
  "sector": "Health Care",
  "industry": "Biotechnology: In Vitro & In Vivo Diagnostic Substances",
  "exchange": "nasdaq",
  "category": "IN VITRO &amp;amp; IN VIVO DIAGNOSTIC SUBSTANCES",
  "address": {
    "street1": "880 WINTER STREET",
    "city": "WALTHAM",
    "state": "MA",
    "zip": "02451"
  },
  "profit": {
    "2009": -17114000,
    "2010": -18196000,
    "2011": -17582000,
    "2012": -23769000,
    "2013": -15849000
  },
  "cash": {
    "2009": 8343000,
    "2010": 2425000,
    "2011": 23874000,
    "2012": 12786000,
    "2013": 7751000
  },
  "earningsPerShare": {},
  "htmlUrl": "http://www.sec.gov/Archives/edgar/data/1407038/000119312514118591/0001193125-14-118591-index.htm",
  "xmlUrl": "http://www.sec.gov/Archives/edgar/data/1407038/000119312514118591/bgmd-20131231.xml"
}